Effect of linagliptin (BI 1356) on the steady-state pharmacokinetics of simvastatin
The grey market can diminish the perceived value of these efforts, leading to potential financial losses and reduced incentives for innovation in drug development
Studies in patients with type 2 diabetes and obesity have demonstrated that the use of SGLT2 inhibitors, particularly empagliflozin, not only increases overall cancer risk but also significantly elevates the risk of bladder cancer [10, 108]
The FDA prescribing information for Ozempic states plainly that "OZEMPIC causes a delay of gastric emptying." That slowdown is helpful for appetite and blood sugar
Trial design determines who was studied, how doses were escalated, what outcomes were measured, and which side effects were monitored
Alqahtani Y, Wang S, Huang Y, Najmi A, Guan X